{
  "ticker": "JAZZ",
  "company_name": "Jazz Pharmaceuticals",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03393611",
      "title": "CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Relapsed Adult Acute Myeloid, Myelodysplastic Syndromes, Previously Treated",
      "start_date": "2012-11-30",
      "completion_date": "2021-11-18",
      "enrollment": 0,
      "sponsor": "Weill Medical College of Cornell University"
    },
    {
      "nct_id": "NCT01424566",
      "title": "A Two-Part Study of Sativex\u00ae Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Pain, Advanced Cancer",
      "start_date": "2012-06-29",
      "completion_date": "2015-12-28",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT02091375",
      "title": "Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Epilepsy, Dravet Syndrome",
      "start_date": "2015-03-30",
      "completion_date": "2015-11-26",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT03485729",
      "title": "ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Endometrial Cancer Recurrent",
      "start_date": "2018-03-21",
      "completion_date": "2023-01-19",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT03335267",
      "title": "Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Leukemia, Myeloid, Acute",
      "start_date": "2017-10-19",
      "completion_date": "2020-05-29",
      "enrollment": 0,
      "sponsor": "Weill Medical College of Cornell University"
    },
    {
      "nct_id": "NCT03134131",
      "title": "Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade Gliomas",
      "status": "NO_LONGER_AVAILABLE",
      "phase": "",
      "condition": "Glioma",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT01323569",
      "title": "Abuse Potential of Sativex",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Evaluation of Abuse Potential of Sativex",
      "start_date": "2008-02",
      "completion_date": "2008-06",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT03555955",
      "title": "A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes",
      "start_date": "2018-11-20",
      "completion_date": "2021-05-26",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT01843634",
      "title": "Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia",
      "status": "COMPLETED",
      "phase": "EARLY_PHASE1",
      "condition": "Acute Myeloid Leukemia",
      "start_date": "2013-08",
      "completion_date": "2015-04",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT02325011",
      "title": "An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex\u00ae in Healthy Subjects With Cannabis Experience.",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Subjects",
      "start_date": "2014-11",
      "completion_date": "2015-02",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE1": 10,
      "PHASE3": 10,
      "PHASE2": 16,
      "": 6,
      "EARLY_PHASE1": 1,
      "PHASE4": 1,
      "PHASE1, PHASE2": 4,
      "NA": 2
    },
    "by_status": {
      "COMPLETED": 30,
      "TERMINATED": 6,
      "NO_LONGER_AVAILABLE": 3,
      "RECRUITING": 5,
      "APPROVED_FOR_MARKETING": 1,
      "WITHDRAWN": 2,
      "NOT_YET_RECRUITING": 2,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 6,
    "completed_trials": 30,
    "conditions": [
      "Acute Lymphoblastic Leukemia (ALL), Newly Diagnosed Philadelphia Chromosome Negative, Aged 60 Years or Older",
      "Acute Myeloid Leukemia",
      "Acute Myeloid Leukemia (AML) in Remission",
      "Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS)",
      "Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Diffuse Large Cell Lymphoma, Gray Zone Lymphoma, Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, Hodgkin Lymphoma",
      "Adenovirus",
      "Anxiety Disorder",
      "B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, T Acute Lymphoblastic Leukemia",
      "Bone Marrow Transplant Complications, Sinusoidal Obstruction Syndrome, Veno Occlusive Disease, Hepatic, Stem Cell Transplant Complications",
      "Colorectal Neoplasms",
      "Coronary Artery Stenosis",
      "Covid19",
      "Daytime Sleepiness",
      "Diffuse Intrinsic Pontine Glioma, Glioma, Malignant",
      "Early Life Adversity, Trauma, Stress",
      "Endometrial Cancer Recurrent",
      "Epilepsy, Dravet Syndrome",
      "Essential Thrombocythemia, Myelofibrosis, Myeloproliferative Neoplasm, Polycythemia Vera, Secondary Acute Myeloid Leukemia",
      "Essential Tremor",
      "Evaluation of Abuse Potential of Sativex",
      "Fibromyalgia",
      "Fragile X Syndrome",
      "Gastrointestinal Malignancies",
      "Glioma",
      "HER2-Positive Advanced Biliary Tract Cancer",
      "HER2-expressing Cancers",
      "Healthy Subjects",
      "Hematologic Disease",
      "Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes",
      "High Risk Acute Myeloid Leukemia",
      "Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex",
      "Leukemia, Myeloid, Acute",
      "Multiple Myeloma",
      "Multiple Sclerosis",
      "Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Relapsed Adult Acute Myeloid, Myelodysplastic Syndromes, Previously Treated",
      "Narcolepsy",
      "Non-Small Cell Lung Cancer, Sarcoma, Head &Amp; Neck Cancer, Colorectal Carcinoma, Endometrial",
      "Obstructive Sleep Apnea",
      "Pain, Advanced Cancer",
      "Parkinson Disease, Tremor",
      "Rett Syndrome, RTT",
      "Schizophrenia, Insomnia Related to Schizophrenia (307.42)",
      "Small Cell Lung Cancer",
      "Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer",
      "Spasticity, Multiple Sclerosis",
      "Transplant-Associated Thrombotic Microangiopathy, Neuroblastoma, High-risk Neuroblastoma, Thrombotic Microangiopathies"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:02:49.296170",
    "search_query": "Jazz Pharmaceuticals",
    "url": "https://clinicaltrials.gov/search?term=Jazz+Pharmaceuticals"
  }
}